Novo Nordisk’s Martin Holst Lange previews obesity pill

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. We’re inching closer to having the first-ever needle-free weight loss drug. That’s thanks to Novo Nordisk, which expects a U.S. approval for its daily pill for chronic…

Read More

Trump’s deportations put California’s immigrant labor force at risk

From citrus farms in the Central Valley to construction sites where homes and businesses are being rebuilt after devastating wildfires in Pacific Palisades, California relies heavily on immigrant workers and entrepreneurs. As the Trump administration continues to ramp up immigration enforcement, industries key to the state’s $4 trillion economy like agriculture, construction and hospitality could…

Read More

The vaccine and public health debate explained

The exterior of the Center for Disease Control and Prevention (CDC) main campus in Atlanta, Georgia, U.S., Aug. 27, 2025. Alyssa Pointer | Reuters The Centers for Disease Control and Prevention is facing a leadership upheaval — and at the center of the shakeup is concern about the agency’s approach to vaccines and U.S. public…

Read More